Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
Choosing which disease modifying drug (DMD) to start is not always easy and sometimes you'll find that you don't get on with the drug you have chosen. In this guest blog, Jane shares her experience of making a decision about treatment.
A lot of people with MS will experience sexual problems at some point in their lives, but yet we often find it hard to speak up about sex and MS. We think this needs to change.
MS Trust supporter Kimberley Carey has designed a stunning pendant necklace to raise awareness and funds for the MS Trust.
When MS Trust supporter Rebecca Morrison signed up to our Alps Trek back in 2016, she could have never imagined just how life-affirming the experience would be. In this blog, she writes about her own journey with MS, what inspired her take on a challenge for the MS Trust, and why she’d encourage others to do the same.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 12, where Hellie ends up stopping the drug, but still remain on the trial.
- Smoking worsens MS
- Gilenya for younger people
- Social networks influence health
- Ten years of the Risk-sharing Scheme
The MS Trust has praised the pioneering work of the MS Risk Sharing Scheme (RSS) as the final results from the scheme are published in the Journal of Neurology, Neurosurgery and Psychiatry today (September 24).
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 11, where Hellie wonders if she will still remain on the trial.
As the final data from the MS Risk-Sharing scheme (RSS) is published in the BMJ, we reflect on how this pioneering scheme has changed the landscape for people living with MS.
On 9 September, our team of 34 runners took on the iconic 13.1-mile route from Newcastle to South Shields.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 10, where Hellie starts taking the drug again, but then has to stop again.
Guest blogger Emily, also known as the wibbly dinosaur, writes about her life after being diagnosed with MS, and why she started blogging to help others who are new to MS.
Don, 86, is a carer to his wife Sandie. He shares his experiences of caring for a loved-one with MS.
The MS Trust is delighted to announce that it will feature in the September BBC Lifeline Appeal at 2.45pm this Sunday (September 16) on BBC One. Please tune in and help us raise awareness of MS and the work of the MS Trust.
- Ocrevus turned down for PPMS
- Ocrevus slows progression
- Prevalence of benign MS
- Statins trial starts in SPMS
- Gilenya effective in childhood MS
The MS Trust is hugely disappointed that NICE is unable to recommend ocrelizumab as an NHS treatment for early primary progressive MS.
In a new blog, a person with MS chronicles her journey taking part in a clinical trial for the drug bexarotene. Part 9, where Hellie gets to see her "impressive" yet alarming liver values.